Antibody-Incorporated Nanomedicines for Cancer Therapy
![](https://medicine.nus.edu.sg/trp/nanomedicine/wp-content/uploads/sites/9/2022/02/adma202109210-fig-0014-m.jpg)
Abstract Antibody-based cancer therapy, one of the most significant therapeutic strategies, has achieved considerable success and progress over the past decades. Nevertheless, obstacles including limited tumor penetration, short circulation half-lives, undesired immunogenicity, and off-target side effects remain to be overcome for the antibody-based cancer treatment. Owing to the rapid development of nanotechnology, antibody-containing nanomedicines that […]